[1]
|
Hirani, N., MacKinnon, A.C., Nicol, L., Ford, P., Schambye, H., Pedersen, A., et al. (2020) Target Inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis. European Respiratory Journal, 57, Article ID: 2002559. https://doi.org/10.1183/13993003.02559-2020
|
[2]
|
Schafer, M.J., White, T.A., Iijima, K., et al. (2017) Cellular Senescence Mediates Fibrotic Pulmonary Disease. Nature Communications, 8, Article No. 14532.
|
[3]
|
Chanda, D., Otoupalova, E., Smith, S.R., Volckaert, T., De Langhe, S.P., Thannickal, V.J. (2019) Developmental Pathways in the Pathogenesis of Lung Fibrosis. Molecular Aspects of Medicine, 65, 56-69. https://doi.org/10.1016/j.mam.2018.08.004
|
[4]
|
邓岳潼, 吕晓东, 庞立健, 等. 基于“三因制宜”探析特发性肺纤维化防治原则研究进展[J]. 中华中医药学刊, 2019, 37(9): 2193-2195.
|
[5]
|
石岩, 庞立健, 刘创, 等. 基于体质学说论特发性肺纤维化中医研究思路[J]. 中医杂志, 2017, 58(11): 926-928.
|
[6]
|
张耀夫, 赵进喜. 赵进喜辨体论治肺间质纤维化[J]. 中医学报, 2020, 35(9): 1934-1938.
|
[7]
|
Nalysnyk, L., Cid-Ruzafa, J., Rotella, P. and Esser, D. (2012) Incidence and Prevalence of Idiopathic Pulmonary Fibrosis: Review of the Literature. European Respiratory Review, 21, 355-361. https://doi.org/10.1183/09059180.00002512
|
[8]
|
Borie, R., Le Guen, P., Ghanem, M., Taillé, C., Dupin, C., Dieudé, P., et al. (2019) The Genetics of Interstitial Lung Diseases. European Respiratory Review, 28, Article ID: 190053. https://doi.org/10.1183/16000617.0053-2019
|
[9]
|
Moore, C., Blumhagen, R.Z., Yang, I.V., Walts, A., Powers, J., Walker, T., et al. (2019) Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 200, 199-208. https://doi.org/10.1164/rccm.201810-1891oc
|
[10]
|
王琦. 中医体质学[M]. 北京: 中国医药科技出版社, 1995: 24.
|
[11]
|
段春磊, 王明航, 周林琼, 等. 肺纤维化中医药治疗述评[J]. 中国中医基础医学杂志, 2023, 29(4): 672-674.
|
[12]
|
吴聪, 罗成, 王玉光, 等. 基于三期九候论治间质性肺疾病经验撷菁[J]. 中华中医药杂志, 2023, 38(4): 1580-1583.
|
[13]
|
Yao, C., Guan, X., Carraro, G., Parimon, T., Liu, X., Huang, G., et al. (2021) Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 203, 707-717. https://doi.org/10.1164/rccm.202004-1274oc
|
[14]
|
杨正, 马明越, 王济, 等. “辨体-辨病-辨证”诊疗模式的创建与临床应用[J]. 现代中医临床, 2017, 24(3): 9-12.
|
[15]
|
Holland, A.E., Fiore, J.F., Bell, E.C., Goh, N., Westall, G., Symons, K., et al. (2014) Dyspnoea and Comorbidity Contribute to Anxiety and Depression in Interstitial Lung Disease. Respirology, 19, 1215-1221. https://doi.org/10.1111/resp.12360
|
[16]
|
陈玉柱. 润燥解毒、化痰活血、消积散结法治疗61例煤工尘肺病的疗效观察[J]. 光明中医, 2010, 25(9): 1594-1598.
|
[17]
|
胡向洁. 肺间质纤维化患者中医体质分布规律研究[D]: [硕士学位论文]. 济南: 山东中医药大学, 2017.
|
[18]
|
李小燕, 何焯根, 陈润东, 等. 300例冠心病患者中医体质类型与血脂水平的相关性分析[J]. 中西医结合心脑血管病杂志, 2015, 13(8): 964-966.
|
[19]
|
陈维克, 张健新, 赵华, 等. 山东省干部保健人群原发性骨质疏松症与中医体质的相关性[J]. 中国医药科学, 2017, 7(19): 12-15.
|
[20]
|
Somogyi, V., Chaudhuri, N., Torrisi, S.E., Kahn, N., Müller, V. and Kreuter, M. (2019) The Therapy of Idiopathic Pulmonary Fibrosis: What Is Next? European Respiratory Review, 28, Article ID: 190021. https://doi.org/10.1183/16000617.0021-2019
|
[21]
|
秦静波, 李竹青, 孟翔鹤, 等. 大健康背景下中医体质学在恶性肿瘤防治中应用的思考[J]. 北京中医药大学学报, 2021, 44(9): 818-823.
|
[22]
|
陈云凤, 刘洪, 李群英, 等. 补肺益肾、化瘀通络法治疗特发性肺间质纤维化的临床研究[J]. 中华中医药杂志, 2014, 29(9): 3030-3032.
|
[23]
|
鞠铮嵘. 肺痿理论-晁恩祥名老中医治疗肺纤维化经验总结[D]: [硕士学位论文]. 北京: 北京中医药大学, 2014.
|
[24]
|
江振国. 川芎嗪注射液治疗肺间质纤维化临床观察[J]. 中国中医药信息杂志, 2013, 20(9): 78-79.
|
[25]
|
赵霞, 卢海燕, 孙轶秋. 120例哮喘患儿中医体质分型研究[J]. 南京中医药大学学报, 2014, 30(1): 27-29.
|
[26]
|
白明华, 王济, 郑燕飞, 等. 基于108015例样本数据的中国人群中医体质类型分布特征分析[J]. 北京中医药大学学报, 2020, 43(6): 498-507.
|